Diabetes Excellence Unit (Q3217202): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the materialized bot - inferring region from the coordinates) |
(Changed label, description and/or aliases in en: translated_label) |
||
| label / en | label / en | ||
Diabetes Excellence Unit | |||
Revision as of 08:33, 12 October 2021
Project Q3217202 in Spain
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Diabetes Excellence Unit |
Project Q3217202 in Spain |
Statements
2,604,967.5 Euro
0 references
5,209,935.0 Euro
0 references
50.0 percent
0 references
1 January 2018
0 references
31 December 2022
0 references
HOSPITAL SAN JUAN DE DIOS
0 references
41°22'58.40"N, 2°10'38.75"E
0 references
08019
0 references
El proyecto "Unidad de Excelencia en Diabetes" tiene tres objetivos: 1. Mejorar nuestros outcomes en diabetes 2. Cambiar procesos y modelo de relación con nuestros pacientes, de forma que sean referencia de innovación organizativa 3. Crear un modelo de referencia internacional, que sea el epicentro de una red de colaboración internacional liderada desde un centro de Catalunya RESULTADOS / ENTREGABLES: ¿ Nuevo modelo asistencial de diagnóstico y tratamiento de la diabetes infantil tipo 1, basado en un modelo de medicina de precisión ¿ Un nuevo modelo de financiación, basado en una transferencia de riesgo al proveedor tecnológico. En el caso de la diabetes tipo 1, de bombas y sensores. El nuevo modelo de relación con el proveedor tecnológico se basará en la compra de servicios y outcomes, no en la compra de tecnología. (Spanish)
0 references
The project "Unity of Excellence in Diabetes" has three objectives: 1. Improve our diabetes outcomes. 2. Change processes and model of relationship with our patients, so that they become organizational innovation¿s reference. 3. Create an international reference model, which shall be the epicenter of an international collaboration network led from a center in Catalonia. RESULTS / DELIVERABLES -New model of diagnosis and treatment of childhood diabetes type 1, based on a model of precision medicine. -A new funding model, based on the transfer of risk to the technology provider. In the case of type 1 diabetes, of pumps and sensors,the new model of relationship with the technology provider will be based on the purchase of services and outcomes, not on the purchase of technology. (English)
0 references
Barcelona
0 references
Identifiers
SA51-006939
0 references